Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Preferred Stock Liabilities (2020 - 2021)

Historic Preferred Stock Liabilities for NeuroPace (NPCE) over the last 2 years, with Q1 2021 value amounting to $141.4 million.

  • NeuroPace's Preferred Stock Liabilities rose 9223.3% to $141.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $141.4 million, marking a year-over-year increase of 9223.3%. This contributed to the annual value of $141.4 million for FY2020, which is N/A changed from last year.
  • NeuroPace's Preferred Stock Liabilities amounted to $141.4 million in Q1 2021, which was up 9223.3% from $141.4 million recorded in Q4 2020.
  • NeuroPace's Preferred Stock Liabilities' 5-year high stood at $141.4 million during Q3 2020, with a 5-year trough of $73.5 million in Q2 2020.